Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity

May Bin-Jumah,1 Sadaf Jamal Gilani,2 Mohammed Asadullah Jahangir,3 Ameeduzzafar Zafar,4 Sultan Alshehri,5,6 Mohd Yasir,7 Chandra Kala,8 Mohamad Taleuzzaman,8 Syed Sarim Imam5 1Biology Department, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 2Department of Ba...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bin-Jumah M, Gilani SJ, Jahangir MA, Zafar A, Alshehri S, Yasir M, Kala C, Taleuzzaman M, Imam SS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	clarithromycin chitosan optimization nanoparticles het-cam antimicrobial assessment Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/de1d1aa0447e48ca9c856c22443ee55e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:de1d1aa0447e48ca9c856c22443ee55e
record_format	dspace
spelling	oai:doaj.org-article:de1d1aa0447e48ca9c856c22443ee55e2021-12-02T11:12:07ZClarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity1178-2013https://doaj.org/article/de1d1aa0447e48ca9c856c22443ee55e2020-10-01T00:00:00Zhttps://www.dovepress.com/clarithromycin-loaded-ocular-chitosan-nanoparticle-formulation-optimiz-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013May Bin-Jumah,1 Sadaf Jamal Gilani,2 Mohammed Asadullah Jahangir,3 Ameeduzzafar Zafar,4 Sultan Alshehri,5,6 Mohd Yasir,7 Chandra Kala,8 Mohamad Taleuzzaman,8 Syed Sarim Imam5 1Biology Department, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 2Department of Basic Health Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 3Department of Pharmaceutics, Nibha Institute of Pharmaceutical Sciences, Rajgir, Nalanda 803116, Bihar, India; 4Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia; 5Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 6College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia; 7Department of Pharmacy, College of Health Science, Arsi University, Asella, Ethiopia; 8Faculty of Pharmacy, Maulana Azad University, Jodhpur 342802, Rajasthan, IndiaCorrespondence: Sadaf Jamal GilaniDepartment of Basic Health Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi ArabiaEmail gilanisadaf@gmail.comSyed Sarim ImamDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaEmail sarimimam@gmail.comPurpose: The topically administered drugs through conventional delivery systems have low bioavailability. Henceforth, the present study was designed to prepare and optimize clarithromycin (CTM)-loaded chitosan nanoparticles (CHNPs) to demonstrate the efficacy against microorganisms.Methods: Clarithromycin-loaded chitosan nanoparticles (CTM-CHNPs) were prepared by ionotropic gelation method. The formulation was optimized by box-Behnken design using the formulation variables like CH (A), STPP concentration (B), and stirring speed (C). Their effects were evaluated on the independent variables like particle size (Y1) and entrapment efficiency (Y2). Further, CTM-CHNPs were evaluated for physicochemical parameters, in-vitro drug release, ex-vivo permeation, bioadhesive study, corneal hydration, histopathology, HET-CAM, and antibacterial study.Results: The optimized formulation (CTM-CHNPopt) showed the low particle size (152± 5 nm), which is desirable for ocular delivery. It also showed high encapsulation (70.05%), zeta potential (+35.2 mV), and was found in a spherical shape. The drug release study revealed a sustained drug release profile (82.98± 3.5% in 12 hours) with Korsmeyer peppas kinetic (R2=0.996) release model. It showed a 2.7-fold higher corneal permeation than CTM-solution. CHNPs did not exhibit any sign of damage to excised goat cornea, which is confirmed by hydration, histopathology, and HET-CAM test. It exhibited significant (P< 0.05) higher antibacterial susceptibility than CTM-solution.Conclusion: The finding of the study concluded that CTM-CHNPs can be used for effective management of bacterial conjunctivitis by increasing the precorneal residence time.Keywords: clarithromycin, chitosan, optimization, nanoparticles, HET-CAM, antimicrobial assessmentBin-Jumah MGilani SJJahangir MAZafar AAlshehri SYasir MKala CTaleuzzaman MImam SSDove Medical Pressarticleclarithromycinchitosanoptimizationnanoparticleshet-camantimicrobial assessmentMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 7861-7875 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	clarithromycin chitosan optimization nanoparticles het-cam antimicrobial assessment Medicine (General) R5-920
spellingShingle	clarithromycin chitosan optimization nanoparticles het-cam antimicrobial assessment Medicine (General) R5-920 Bin-Jumah M Gilani SJ Jahangir MA Zafar A Alshehri S Yasir M Kala C Taleuzzaman M Imam SS Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
description	May Bin-Jumah,1 Sadaf Jamal Gilani,2 Mohammed Asadullah Jahangir,3 Ameeduzzafar Zafar,4 Sultan Alshehri,5,6 Mohd Yasir,7 Chandra Kala,8 Mohamad Taleuzzaman,8 Syed Sarim Imam5 1Biology Department, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 2Department of Basic Health Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 3Department of Pharmaceutics, Nibha Institute of Pharmaceutical Sciences, Rajgir, Nalanda 803116, Bihar, India; 4Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia; 5Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 6College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia; 7Department of Pharmacy, College of Health Science, Arsi University, Asella, Ethiopia; 8Faculty of Pharmacy, Maulana Azad University, Jodhpur 342802, Rajasthan, IndiaCorrespondence: Sadaf Jamal GilaniDepartment of Basic Health Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi ArabiaEmail gilanisadaf@gmail.comSyed Sarim ImamDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaEmail sarimimam@gmail.comPurpose: The topically administered drugs through conventional delivery systems have low bioavailability. Henceforth, the present study was designed to prepare and optimize clarithromycin (CTM)-loaded chitosan nanoparticles (CHNPs) to demonstrate the efficacy against microorganisms.Methods: Clarithromycin-loaded chitosan nanoparticles (CTM-CHNPs) were prepared by ionotropic gelation method. The formulation was optimized by box-Behnken design using the formulation variables like CH (A), STPP concentration (B), and stirring speed (C). Their effects were evaluated on the independent variables like particle size (Y1) and entrapment efficiency (Y2). Further, CTM-CHNPs were evaluated for physicochemical parameters, in-vitro drug release, ex-vivo permeation, bioadhesive study, corneal hydration, histopathology, HET-CAM, and antibacterial study.Results: The optimized formulation (CTM-CHNPopt) showed the low particle size (152± 5 nm), which is desirable for ocular delivery. It also showed high encapsulation (70.05%), zeta potential (+35.2 mV), and was found in a spherical shape. The drug release study revealed a sustained drug release profile (82.98± 3.5% in 12 hours) with Korsmeyer peppas kinetic (R2=0.996) release model. It showed a 2.7-fold higher corneal permeation than CTM-solution. CHNPs did not exhibit any sign of damage to excised goat cornea, which is confirmed by hydration, histopathology, and HET-CAM test. It exhibited significant (P< 0.05) higher antibacterial susceptibility than CTM-solution.Conclusion: The finding of the study concluded that CTM-CHNPs can be used for effective management of bacterial conjunctivitis by increasing the precorneal residence time.Keywords: clarithromycin, chitosan, optimization, nanoparticles, HET-CAM, antimicrobial assessment
format	article
author	Bin-Jumah M Gilani SJ Jahangir MA Zafar A Alshehri S Yasir M Kala C Taleuzzaman M Imam SS
author_facet	Bin-Jumah M Gilani SJ Jahangir MA Zafar A Alshehri S Yasir M Kala C Taleuzzaman M Imam SS
author_sort	Bin-Jumah M
title	Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
title_short	Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
title_full	Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
title_fullStr	Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
title_full_unstemmed	Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
title_sort	clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/de1d1aa0447e48ca9c856c22443ee55e
work_keys_str_mv	AT binjumahm clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT gilanisj clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT jahangirma clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT zafara clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT alshehris clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT yasirm clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT kalac clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT taleuzzamanm clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity AT imamss clarithromycinloadedocularchitosannanoparticleformulationoptimizationcharacterizationocularirritationandantimicrobialactivity
_version_	1718396199771308032

Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity

Ejemplares similares